Abstract
Metazoan development requires robust proliferation of progenitor cells, whose identities are established by tightly controlled transcriptional networks 1. As gene expression is globally inhibited during mitosis, the transcriptional programs defining cell identity must be restarted in each cell cycle 2-5, yet how this is accomplished is poorly understood. Here, we identified a ubiquitin-dependent mechanism that integrates gene expression with cell division to preserve cell identity. We found that WDR5 and TBP, which bind active interphase promoters 6,7, recruit the anaphase-promoting complex (APC/C) to specific transcription start sites (TSS) during mitosis. This allows APC/C to decorate histones with K11/K48-branched ubiquitin chains that recruit p97/VCP and the proteasome and ensure rapid expression of pluripotency genes in the next cell cycle. Mitotic exit and transcription re-initiation are thus controlled by the same regulator, APC/C, which provides a robust mechanism to maintain cell identity through cell division.
Keywords: ubiquitin, K11/K48-branched chains, p97/VCP, embryonic stem cells, self-renewal, mitotic bookmarking, APC/C
Stem cell self-renewal endows organisms with the capacity to establish or regenerate their many tissues, yet its misregulation contributes to tumorigenesis, tissue degeneration or aging 8. While tightly controlled transcriptional networks establish the identity of self-renewing stem cells during interphase 1, changes in chromatin architecture and transcription factor activity restrict mRNA synthesis during mitosis 9. Stem cells must therefore restart their gene expression programs each time they enter a new cell cycle 4,5, which is facilitated by promoter elements that remain unwound during mitosis 2, hypersensitive to DNase I 2,10, and accessible to RNA polymerase II and transcription factors, such as the TATA-box binding protein TBP 3,11-13. How dividing cells retain hallmarks of interphase transcription to preserve their identity is incompletely understood.
The APC/C maintains hESC identity
To understand how pluripotency is preserved through cell division, we fused GFP to the OCT4 locus of human embryonic stem cells. Diploid OCT4GFP-hESCs responded to differentiation cues with similar efficiency as their untagged counterparts (Extended Data Fig. 1a, b). Using lentiviral infection with pooled shRNAs, we depleted ~900 enzymes and effectors of ubiquitylation, which controls cell division and differentiation 14; propagated OCT4GFP-hESCs in pluripotency medium or briefly induced differentiation by neural conversion; and deep sequenced populations with low versus high levels of OCT4GFP (Fig. 1a). shRNAs that decreased OCT4GFP abundance in self-renewing hESCs target pluripotency factors, whereas shRNAs that sustained OCT4GFP expression upon neural conversion deplete proteins needed for robust differentiation.
As pluripotency factors, we recovered the positive control OCT4 as well as known stem cell E3s, such as DDB1, TRIM28, and UBR5 15-17 (Fig. 1b; Extended Data Fig. 1c). Consistent with the need for hESCs to preserve genomic and proteomic integrity, we identified DNA repair (DDB1, RNF168, USP7) and quality control pathways (BAG6, HUWE1, PSMA1, PSMA6, UBR5, UBXN7). Many of the latter enzymes bind or produce K11/K48-branched ubiquitin chains 18, which we confirmed in hESCs (Extended Data Fig. 1d). Physiological pairs of E3s and deubiquitylases (DUBs), such as HUWE1 and USP7, clustered according to their opposing activities. Importantly, a subunit of the APC/C, APC2, was required for pluripotency, whereas its counteracting DUB, USP44 19, supported differentiation (Fig. 1b, Extended Data Fig. 1c, e). Other APC/C subunits and APC/C-specific E2 enzymes scored as pluripotency factors, with p-values slightly below our stringent screen cutoff (Extended Data Fig. 1c).
We confirmed that depletion of APC/C subunits, its co-activator CDC20, or APC/C-specific E2s inhibited hESC pluripotency, as revealed by decreased levels of OCT4 and NANOG (Fig. 1c; Extended Data Fig. 2a-c). While less pronounced, APC2-depletion reduced OCT4 and NANOG mRNA abundance (Extended Data Fig. 2d). hESCs arrested in S phase and unable to enter mitosis did not require APC/C for pluripotency (Extended Data Fig. 2e), indicating that APC/C acts during cell division. However, it was unlikely that APC/C-inhibition interfered with pluripotency simply by stalling mitotic progression, as loss of the APC/C-specific E2 UBE2C diminished OCT4 and NANOG levels without affecting the G2/M population (Fig. 1c; Extended Data Fig. 2f). Collectively, these findings indicated that the essential mitotic regulator APC/C also helps preserve the stem cell state, identifying it as a strong candidate for maintaining cell identity through cell division.
APC/C cooperates with WDR5 in hESCs
We speculated that identification of APC/C or USP44 substrate adaptors required for pluripotency might point to ubiquitylated proteins that preserve hESC identity. Using mass spectrometry, we found that USP44, in addition to known partners, engaged WDR5, a chromatin-associated factor that binds methylated histone H3K4 at active interphase promoters 6,7,20 (Fig. 1d). Endogenous APC/C also interacted with WDR5 during mitosis (Fig. 1d), which was confirmed by reciprocal purification of WDR5 (Extended Data Fig. 3a). In addition, mitotic WDR5 bound the transcription factor TF-IID, including TBP, as well as chromatin remodelers INO80 and CHD1 (Extended Data Fig. 3a).
As with APC/C and TF-IID/TBP 21, depleting WDR5 diminished OCT4 and NANOG levels in hESCs (Extended Data Fig. 3b). hESCs unable to enter mitosis did not require WDR5 for pluripotency (Extended Data Fig. 2e), suggesting that WDR5 acts during cell division. Consistently, loss of WDR5 in hESCs decreased the levels of K11-linked and K11/K48-branched ubiquitin chains - the mitotic products of APC/C 18 - to a similar extent as depletion of APC2 (Extended Data Fig. 3b). As in mESCs 20, loss of WDR5 did not affect mitotic duration (Extended Data Fig. 3c), yet co-depletion of WDR5 and APC2 caused hESCs to die shortly after exiting mitosis (Extended Data Fig. 3d-g). These findings suggested that WDR5 cooperates with APC/C to ensure hESC identity and survival, whereas it does not impinge on APC/C’s role in controlling cell division.
Reciprocal immunoprecipitations of endogenous proteins from somatic cells showed that APC/C, WDR5, and TBP only engage each other during early mitosis, when APC/C binds CDC20 (Fig. 2a, b). A similar mitotic increase in the APC/C-WDR5 interaction was seen in hESCs (Extended Data Fig. 3h). Sequential affinity-purifications revealed that APC/C, WDR5, and TBP were part of the same complex (Fig. 2c), whose formation depended on WDR5 (Fig. 2d). In contrast to the APC/C, WDR5 engaged USP44 also during interphase (Extended Data Fig. 3i).
WDR5 uses distinct surfaces to recognize WBM- (WDR5-binding) and WIN- (WDR5-interacting) motifs 6. Disrupting its ability to bind WIN motifs (WDR5ΔWIN) blocked association of WDR5 with APC/C and USP44, but not TBP (Extended Data Fig. 3i; Extended Data Fig. 4a-c). Accordingly, the compound MM-102, which targets WDR5’s WIN-binding site 22, prevented WDR5 from binding APC/C (Extended Data Fig. 4d), and WDR5ΔWIN did not sustain hESC pluripotency (Extended Data Fig. 4e). WDR5’s ability to detect WBM-motifs (WDR5ΔWBM) was not required for APC/C recognition, but needed to bind TBP (Extended Data Fig. 4a, c).
Crosslinking experiments revealed that WDR5, but not WDR5ΔWIN, binds APC/C close to CDC20 and the catalytic site composed of APC2 and APC11 (Extended Data Fig. 5a). By in vitro translation, we identified APC2 as specific binding partner of WDR5 (Extended Data Fig. 5b, c). We confirmed these findings by negative-stain electron microscopy, which showed that WDR5 is situated near CDC20 and docks against APC2 and APC11 (Fig. 2e).
Despite its proximity to APC/C’s active site, we could not detect APC/C-dependent WDR5 ubiquitylation, nor did excess WDR5 prevent modification of APC/C substrates (Extended Data Fig. 6a, b). Instead, mitotic WDR5-complexes, which contain APC/C (Fig. 2b; Extended Data Fig. 3a), supported the in vitro ubiquitylation of canonical APC/C substrates (Fig. 2f; Extended Data Fig. 6c). Mitotic WDR5 also co-precipitated K11-linked chains produced in cells (Extended Data Fig. 6d), which was dependent upon UBE2S (Extended Data Fig. 6e). We conclude that WDR5 binds active APC/C without being ubiquitylated itself, suggesting that it is a co-adaptor that delivers APC/C to specific, likely chromatin-bound substrates. For the remainder of this study, we denote the APC/C-WDR5 complex as APC/CWDR5.
APC/CWDR5 polyubiquitylates histones
To identify APC/CWDR5 substrates, we used an approach established for SCF E3s 23. We fused WDR5 to ubiquitin-binding domains of HHR23B or UBQLN2, which detect K11/K48-branched chains produced by APC/C 18, and purified both constructs under conditions of low or high APC/C activity. Ubiquitylated substrates were expected to be trapped by both fusions in cells with active APC/C. These experiments identified histones as likely APC/CWDR5 substrates (Fig. 3a).
In vitro reconstitution using human histone H2A/H2B dimers and H3/H4 tetramers, or X. laevis H2A/H2B dimers and octamers, revealed efficient APC/C-dependent ubiquitylation of H2A, H2B, and H3, but not H4 (Fig. 3b; Extended Data Fig. 7a-c). H2A/H2B dimers, octamers, and polynucleosomes were also strongly ubiquitylated by WDR5-bound APC/C and by endogenous APC/C purified from hESCs (Fig. 3c; Extended Data Fig. 7b-d). Histone polyubiquitylation occurred at multiple sites (Fig. 3d), including H2B-Lys120, whose monoubiquitylation leads to transcriptional activation and is negatively regulated by USP44 24.
In contrast to mitotic APC/C, APC/C obtained from asynchronous or S phase cells did not modify histones (Extended Data Fig. 7e). APC/C-dependent histone polyubiquitylation was also blocked by depletion of APC/C’s mitotic co-activator CDC20, addition of the APC/C-inhibitor EMI1 or mutation of Lys11 of ubiquitin (Fig. 3e, f; Extended Data Fig. 7f, g). H2B ubiquitylation was outcompeted by a canonical APC/C substrate, but less so by a D-box mutant substrate (Extended Data Fig. 7h), which indicated that histones are recognized by the D-box co-receptor composed of CDC20 and APC10 25.
Denaturing purifications of K11/K48-branched chains revealed abundant ubiquitylation of endogenous H2B during early mitosis, at a time when CDC20 is decorated with such conjugates (Fig. 3g). Underscoring APC/C’s role, H2B modification with K11/K48-linked chains was strongly reduced by UBE2C and UBE2S depletion (Fig. 3h). Ubiquitylated H2B accumulated upon proteasome inhibition (Fig. 3i; Extended Data Fig. 7i), consistent with K11/K48-branched conjugates targeting proteins for degradation 18,26. We conclude that APC/CWDR5 modifies multiple histones with K11/K48-branched ubiquitin chains during mitosis.
APC/C acts at transcription start sites
As total histone levels did not drop during mitotic exit (Extended Data Fig. 8a), we hypothesized that APC/CWDR5 targets histones at select chromosome locations. To identify this population, we performed genome-wide MNase/ChIPseq analysis of K11-linked chains, WDR5, and TBP in prometaphase hESCs. Because mitotic K11-linkages are assembled by APC/C 18,27, tracking this chain type allowed us to monitor APC/C even if it interacted with its targets only transiently. MNase was used, as sonication fragmented polymeric ubiquitin chains and reduced the specific ChIPseq signal (Extended Data Fig. 8b).
Strikingly, K11-linked and K11/K48-branched chains, i.e. active APC/C, accumulated at specific genes in mitotic hESCs that were co-occupied by WDR5 and TBP (Fig. 4a, b; Extended Data Fig. 8c-e). Chromatin-bound K11-linked chains were abundant during early mitosis, when APC/C is activated by CDC20, but undetectable during late G1 or early S phase, when APC/C is inactive (Fig. 4c-e). By contrast, WDR5 and TBP were found at these promoters throughout the cell cycle (Fig. 4b). Depletion of CDC20, UBE2S, or WDR5, and chemical inhibition of WDR5, strongly reduced K11-linked chains at APC/CWDR5 target genes (Fig. 4f; Extended Data Fig. 8f, g). By heterologous expression of CDC20 and WDR5, we showed that mitotic APC/CWDR5 also associated with specific genes in somatic cells (Extended Data Fig. 8h).
The majority of APC/CWDR5 target sites were within 100 base pairs of the TSS, a location containing TBP-binding sites, as confirmed for select targets by ChIP-qPCR (Extended Data Fig. 8i. j). Gene ontology analyses revealed that most APC/CWDR5 target genes encode proteins involved in ribosome function (GO:0003735, p=1.2×10−56) and mRNA translation (GO:0006413, p=2.2×10−59). These genes are among the very first to be expressed upon mitotic exit 4, dependent upon WDR5 and MYC 6,28. Accordingly, APC/CWDR5-target genes were strongly bound by the stem cell transcription factors MYC, OCT4, and NANOG (Fig. 4g; Extended Data Fig. 8k), while transcription factors linked to differentiation did not accumulate at these sites (Extended Data Fig. 9). When we compared the APC/CWDR5 target set from 293T cells with gene expression profiles, we also noticed strong overlaps with hESC lines (Extended Data Fig. 10a).
Given the enrichment of APC/CWDR5 at the TSS of pluripotency genes and its requirement for self-renewal, we asked whether APC/CWDR5 controls transcription of its target genes. Strikingly, depletion of WDR5 strongly downregulated only those genes that were marked by K11-linked chains, WDR5, and TBP during mitosis (Fig. 4h; Extended Data Fig. 10b, c). qRT-PCR analyses of nascent mRNAs using oligonucleotides spanning intron-exon junctions showed that APC/CWDR5 targets were expressed immediately upon mitotic exit, dependent on WDR5 (Fig. 4i; Extended Data Fig. 10d). APC/CWDR5-target genes are expressed at high levels (Extended Data Fig. 10e), and hence, particularly reliant on rapid re-activation after mitosis. Polyubiquitylation by APC/CWDR5 therefore promotes early postmitotic expression of genes controlled by stem cell transcription factors.
APC/C recruits p97 and the proteasome
Consistent with K11/K48-branched chains recruiting the cellular degradation machinery 18,26, the p97/VCP adaptor UBXN7 and proteasome subunits scored in our screen (Fig. 1b). p97/VCPUBXN7 captured K11/K48-modified H2B in vitro (Extended Data Fig. 10f) and strongly bound K11/K48-ubiquitylated H2B in cells (Extended Data Fig. 10g). Moreover, p97/VCP-inhibition by NMS-873 caused the same strong increase in K11/K48-ubiquitylation of H2B as proteasome inhibition (Extended Data Fig. 10h). Both MNase/ChIPseq and ChIP-qPCR experiments revealed that p97/VCP and the proteasome were required for loss of ubiquitylated proteins from the TSS of APC/CWDR5 targets upon mitotic exit (Extended Data Fig. 10i, j). These findings suggest that APC/CWDR5 might act by destabilizing histones at specific TSSes during mitosis.
Discussion
Our findings reveal a mechanism of how cell identity is preserved through cell division (Extended Data Fig. 10k). WDR5 and TBP bind promoters of genes transcribed in interphase. When cells enter mitosis, WDR5 and TBP remain associated with their targets, but instead of recruiting RNA polymerase II, they deliver APC/C to TSSes demarcated by the pluripotency factors MYC, OCT4, and NANOG. There, the APC/C decorates histones with K11/K48-branched chains, which attract p97/VCP and the proteasome. We propose that histone degradation opens the TSS for rapid postmitotic expression of pluripotency genes. By also triggering mitotic exit 29, APC/C therefore tightly coordinates cell division and gene expression regulation.
The new co-factor WDR5 binds APC/C through the same surface as it engages the MLL1 methyltransferase, another regulator of postmitotic gene expression 30. Histone methylation might strengthen the interaction of WDR5 with promoters, which could facilitate subsequent recruitment of APC/C. WDR5 also engages OCT4, MYC, and TF-IID/TBP, which all bind APC/CWDR5 target genes and play vital roles in mitotic bookmarking. WDR5 thus appears to orchestrate distinct steps in mitotic gene expression regulation by mediating transcription factor recruitment, histone methylation, and nucleosome destabilization.
Partial APC/C inhibition in neural progenitors triggered similar cell differentiation as noted upon loss of APC/CWDR5 in hESCs 31. Conversely, cellular reprogramming and somatic cell nuclear transfer are more efficient during mitosis 32,33, at times that coincide with APC/CWDR5-dependent histone ubiquitylation. This further implies a role for APC/CWDR5 in pluripotency control, which comes with practical implications: if APC/CWDR5 acts in cancer stem cells as in hESCs, combinations of APC/C- and WDR5-inhibitors might impede self-renewal of disease-driving cell populations and should be tested for their efficiency in cancer therapy.
Methods
Mammalian cell culture
Human embyronic kidney (HEK) 293T and HeLa cells were maintained in DMEM plus 10% fetal bovine serum. Plasmid transfections were performed using polyethylenimine (PEI) at a 1:3 ratio of DNA (in μg) to PEI (in μl at a 1 mg ml−1 stock concentration). siRNA transfections were performed using 40 nM of indicated siRNAs and a 1:400 dilution of RNAiMAX transfection reagent (Thermo Fisher, 13778150). Lentiviruses were produced in HEK 293T cells by cotransfection of lentiviral- and packaging plasmids using Lipofectamine® 2000 transfection reagent (Thermo, 11668027). Viruses were harvested 48 h post transfection, concentrated using the Lenti-X concentrator (Takara, 631232), aliquoted, and stored at −80°C for later use.
Human embyronic stem cells (WiCell, WA01/H1) were grown in mTeSR™1 media (StemCell Technologies, 85850) on hESC-qualified Matrigel-coated plates (Corning, 354277) with daily media change. H1s were passaged by collagenase (StemCell Technologies, 07909) for routine maintenance or accutase (StemCell Technologies, 07920) for siRNA transfections, lentiviral infections, or when single cells were required. For siRNA transfections, single cell suspensions of H1s were generated by accutase treatment and 2–5 × 105 cells were seeded on a Matrigel-coated well of a 6-well plate with 1.8 ml of mTeSR™1 containing 10 μM of Y-27632 (StemCell Technologies, 72308) and a 0.2 ml mixture of indicated siRNAs (at a final concentration of 40 nM) and a 1:400 dilution of RNAiMAX transfection reagent buffered in Opti-MEM. For lentiviral infections, single cell suspensions of H1s were generated by accutase treatment and 1.5–3 × 105 cells were seeded on a Matrigel-coated well of a 6-well plate with 2 ml of mTeSR™1 containing 10 μM of Y-27632, polybrene (at a final concentration of 6 μg ml−1), and lentiviruses produced from HEK 293Ts (see above) for 2 h. The media was immediately exchanged with 2 ml of fresh mTeSR™1 containing 10 μM of Y-27632 only. hESCs were drug-selected 24–48 h post infection.
Generation of OCT4-EGFP-P2A-PUROR hESCs
The OCT4 locus was targeted for gene editing in H1s by TALE nucleases as described in Hockemeyer et al. (2011). An in-frame fusion, consisting of eGFP followed by the self-cleaving P2A peptide and the puromycin resistance gene (puromycin N-acetyltransferase), was generated at the C-terminus of the OCT4 locus. Briefly, single cell suspensions of H1s were generated by accutase treatment and 1 × 107 cells were resuspended in ice-cold 1×PBS with 40 μg of the DONOR plasmid and 5 μg each of the TALEN plasmids (T4 and T8). Cells were electroporated in a 0.4-cm cuvette at 250 V and 500 μF with the Gene Pulser II eletroporating system (Bio-Rad). Electroporated cells were immediately resuspended in mTeSR™1, washed to remove lysed debris, and seeded on two Matrigel-coated 15-cm plates in mTeSR™1 containing 10 μM of Y-27632. H1s were selected for 10–14 days with puromycin (at a final concentration of 0.5 μg mg−1) 72 h post electroporation. Colonies were manually scored and transferred to fresh plates. A single allele of the OCT4 locus was fused with the EGFP-P2A-PUROR cassette as verified by Southern blot analysis (data not shown). Karyotype analysis was performed by WiCell.
Neural conversion of hESCs
Neural induction of hESCs were performed as described 35, using STEMdiff™ Neural Induction Medium (StemCell Technologies, 05839). Single cell suspensions of H1s were generated by accutase treatment and 1.5×106 cells were seeded in a well of 6-well plate with 4 ml of STEMdiff™ Neural Induction Medium containing 10 μM Y-27632. Cells were treated with daily media changes and harvested when indicated.
Ultracomplex shRNA screen
The shRNA library was constructed as described 36. Briefly, the shRNA library was divided into four sub-libraries, cloned into lentiviral expression vectors, and transfected into HEK 293T cells with TransIT®-293 transfection reagent (Mirus, MIR 2700) for virus production. hESCs were infected with lentiviruses overnight and cultured in mTeSR™1 for six days or in mTeSR™1 for six days followed by STEMdiff™ Neural Induction Medium for one day. hESCs were then FACS-sorted using an INFLUX cell sorter (BD) at the Flow Cytometry Core Facility at UC Berkeley. Cells were sorted based the strength of their GFP expression into three populations. Sequencing libraries were prepared from sorted cells as described 36, sequenced on a HiSeq 2000 (Illumina), and analyzed using described scripts 36.
Cell synchronization
HeLa cells were first synchronized in S phase by addition of thymidine (at a final concentration of 2 mM) for 24 h. S phase cells were washed with 1×PBS to remove excess thymidine and released into fresh media (DMEM/10% FBS) for 3 h. To arrest cells in prometaphase, released cells were treated with S-trityl-L-cysteine (Sigma, 164739) (at a final concentration of 5 μM) for 12–14 h. Finally, prometaphase cells were collected by vigorous pipetting, washed with 1×PBS, and used for downstream applications, including immunoprecipitation assays and/or Western blot analyses, or frozen in liquid nitrogen and stored at −80°C for later use. For cell cycle studies, prometaphase cells were released into fresh media and collected at indicated time points. For drug inhibition studies, cells were released into media containing 2 μM carfilzomib (Selleck, PR-171), 20 μM (R)-MG132 (Cayman, 13697) and/or 10 μM NMS-873 (Sigma, SML1128) for indicated times. For depletion studies, HeLa cells were transfected with 40 nM of indicated siRNAs and a 1:400 dilution of RNAiMAX transfection reagent (Thermo Fisher, 13778150) 24 h prior to synchronization.
Mitotic enrichment of HEK 293Ts and H1s was achieved by adding STLC (at a final concentration of 5 μM) to the culture media for 14–16 h.
Purification of APC/C and APC/CWDR5 complexes
Human APC/C and APC/CWDR5 complexes were purified from HeLa extracts synchronized in prometaphase (see section on Cell synchronization). To purify APC/CWDR5, HeLa cells were first PEI-transfected with 5 μg of pCMV 3×FLAGWDR5 (per 15-cm plate) for 24 h prior to synchronization. Harvested prometaphase pellets were lysed in lysis buffer (20 mM HEPES, pH 7.4, 5 mM KCl, 150 mM NaCl, 1.5 mM MgCl2, 0.1% Nonidet P-40, 1× cOmplete™ protease inhibitor cocktail (Roche, 04693159001), and 1 μl of benzonase (Millipore, 70746) per 15-cm plate). Detergent lysed cells were then subjected to a high speed spin (20,000 × g) to remove cellular debris and the clarified extract was pre-cleared with protein G-agarose resin (Roche, 11719416001). APC/C was purified with anti-CDC27 antibody (sc-9972, SCBT) pre-coupled to protein G-agarose resin for 3 h at 4°C, while APC/CWDR5 was purified with anti-FLAG® M2 affinity resin (Sigma, A2220) for 1.5 h at 4°C. APC/C-coupled beads were washed 5× with lysis buffer (minus inhibitors and benzonase) prior to use.
Purification of recombinant proteins
WDR5 and WDR5WIN were cloned into a pMAL expression vector containing a C-terminal 6×HIS tag and expressed in BL21-CodonPlus (DE3)RIL cells. Transformed cells were grown at 37°C to an OD600 of 0.5 in LB broth containing 100 μg ml−1 ampicillin, 34 μg ml−1 chloramphenicol, and 0.2% glucose, chilled on ice for 30 min, induced with 100 μM isopropyl β–D–1-thiogalactopyranoside (IPTG) for 6 h at 16°C, and harvested by centrifugation. Harvested cells were resuspend with lysis buffer (20 mM HEPES, pH 7.4, 300 mM NaCl, 2 mM 2-mercaptoethanol (BME), 1 mM EDTA, 10% glycerol, 0.2 mg ml−1 lysozyme, 1 mM phenylmethylsulfonyl fluoride (PMSF), and 0.1% Triton X-100), incubated on ice for 30 min, sonicated, and clarified by high speed centrifugation. The clarified extract was supplemented with 20 mM imidazole and bound to Ni-NTA resin (Qiagen, R90110) (2 ml of slurry per 1 l of bacterial culture) for 1 h at 4°C. The resin was then washed 5× with wash buffer (20 mM HEPES, pH 7.4, 300 mM NaCl, 2 mM BME, 1 mM EDTA, 10% glycerol, and 20 mM imidazole) and eluted 2× with elution buffer (20 mM HEPES, pH 7.4, 300 mM NaCl, 2 mM BME, 1 mM EDTA, 10% glycerol, and 300 mM imidazole). The elutions were pooled, dialyzed overnight in dialysis buffer (20 mM HEPES, pH 7.4, 300 mM NaCl, 2 mM BME, 1 mM EDTA, and 10% glycerol), concentrated, aliquoted, snap frozen in liquid nitrogen, and stored at −80°C for later use.
Securin and its variants were cloned into a pET28 expression vector containing an N-terminal 6×HIS tag followed by a TEV-protease cleavage site and expressed in LOBSTR BL21(DE3)-RIL cells. Transformed cells were grown at 37°C to an OD600 of 0.5 in LB broth containing 100 μg ml−1 ampicillin and 34 μg ml−1 chloramphenicol, chilled on ice for 30 min, induced with 100 μM IPTG for 14–16 h at 16°C. Induced cells were centrifuged, resuspended in lysis buffer (20 mM HEPES, pH 7.4, 300 mM NaCl, 2 mM BME, 10% glycerol, 0.2 mg ml−1 lysozyme, 1 mM PMSF, and 0.1% Triton X-100), incubated on ice for 30 min, sonicated, and clarified by high speed centrifugation. The clarified extract was supplemented with 20 mM imidazole and bound to Ni-NTA resin (2 ml of slurry per 1 l of culture) for 1 h at 4°C. The resin was then washed 5× with wash buffer (20 mM HEPES, pH 7.4, 300 mM NaCl, 2 mM BME, 10% glycerol, 0.1% Triton X-100, and 20 mM imidazole) and eluted by TEV cleavage. The eluate was desalted using a PD10 column, concentrated, aliquoted, snap frozen, and stored at −80°C for later use.
p97/VCP was cloned into a pMAL expression vector and expressed in BL21-CodonPlus (DE3)RIL cells. Transformed cells were grown at 37°C to an OD600 of 0.5 in LB broth containing 100 μg ml−1 ampicillin and 34 μg ml−1 chloramphenicol, chilled on ice for 30 min, induced with 0.5 mM IPTG overnight at 18°C. Induced cells were centrifuged, resuspended in lysis buffer (20 mM Tris 7.4, 300 mM NaCl, 5% glycerol, 0.2 mg ml−1 lysozyme, 1 mM PMSF, and 0.1% Triton X-100), incubated on ice for 30 min, sonicated, and clarified by high speed centrifugation. The clarified extract was bound to amylose resin (NEB, E8021) (2 ml of slurry per 1 l of culture) for 45 min at 4°C. The resin was then washed 3× with 1×PBS, resuspend in 1×PBS containing 2 mM DTT, and stored at 4°C for up to 1 month. Recombinant 6xHISp47/NSFL1C and 6xHISUBXN7 were purified from methods described in Yau et al. (2017).
In vitro transcription/translation (IVT/T) of substrates
All in vitro synthesized substrates were cloned under the SP6 promoter. The corresponding plasmids can be found in Supplementary Table 1. 35S-labeled substrates were generated by incubating 3 μl (400 ng) of plasmid DNA in 20 μl of rabbit reticulocyte lysate (Promega, L2080) supplemented with 2 μl of 35S-Met (PerkinElmer, NEG009H001MC) for 1 h at 30°C. Reactions were terminated by rapid dilution with 1×PBS. 35S-labeled substrates were used for in vitro ubiquitylation assays and/or MBP binding studies.
In vitro ubiquitylation
In vitro ubiquitylation assays were performed in a 10 μl reaction volume: 0.25 μl of 10 μM E1 (250 nM final), 1 μl of 10 μM UBE2C (1 μM final), 1 μl of 10 μM UBE2S (1 μM final), 1 μl of 10 mg ml−1 ubiquitin (1 mg ml−1 final) (Boston Biochem, U-100H), 1 μl of 100 mM DTT, 1.5 μl of energy mix (150 mM creatine phosphate, 20 mM ATP, 20 mM MgCl2, 2 mM EGTA, pH to 7.5 with KOH), 2.25 μl of 1×PBS, 1 μl of 10× ubiquitylation assay buffer (250 mM Tris 7.5, 500 mM NaCl, and 100 mM MgCl2), and 3 μl of substrate (in vitro translated or recombinant) were pre-mixed and added to 5 μl of APC/C- or APC/CWDR5-purified bed resin (see section on Purification of APC/C and APC/CWDR5). Reactions were performed at 30°C with shaking for 30 min unless noted otherwise. Reactions were stopped by adding 2× urea sample buffer and resolved on SDS-acrylamide gels. E1, UBE2C, and UBE2S were purified as described in Meyer and Rape (2014). Recombinant human H2A/H2B dimers (NEB, M2508S), recombinant X. laevis H2A/H2B dimers and octamers, recombinant human H3/H4 tetramers (NEB, M2509S), or purified human nucleosomes (EpiCypher, 16-0003) were used at a final concentration of 500 nM.
MBP binding studies
For IVT/T binding assays, 10 μl of 35S-labeled substrate was diluted down to 400 μl with pre-chilled 1×PBS containing 0.1% Nonidet P-40 and mixed with 2 μl of 1 mg ml−1 of MBP-fused bait (see section on Purification of recombinant proteins) and 8 μl of amylose slurry (NEB, E8021). The binding was performed for 2 h at 4°C with mixing and the amylose resin was subsequently washed 3× with 1×PBS. The bound prey was eluted with 2× urea sample buffer, resolved on an SDS-acrylamide gel, and visualized by a Typhoon scanner.
For co-adapter-bound p97/VCP binding studies, co-adaptor-bound p97/VCP resin was made by mixing 0.1 ml of p97/VCP-coupled amylose slurry (see section on Purification of recombinant proteins) with 0.2 ml of recombinant 6xHISp47/NSFL1C or 6xHISUBXN7 and 0.3 ml of 1×PBS containing 4 mM DTT for 45 min at 4°C. The resin was washed 3× with 1×PBS containing 2 mM DTT and stored at 4°C for up to two weeks. Ubiquitylated H2A/H2B dimers (see section on In vitro ubiquitylation) were added to 6 μl of co-adaptor-bound p97/VCP slurry brought up in 0.6 ml of 1×PBS, incubated for 20 min at 4°C, washed 5× with 1×PBS, eluted with 2× urea sample buffer, and resolved on an SDS-acrylamide gel.
Crosslinking studies
APC/C complexes were first purified from HeLa cells synchronized in prometaphase. Prior to crosslinking, a 200 μM working stock of the sulfhydryl-reactive and homobifunctional crosslinker 1,4-bismaleimidobutane (BMB) was prepared in DMSO and a 20 μM solution of recombinant MBPWDR5 was pre-treated with tris(2-carboxyethyl)phosphine (TCEP) (at a final concentration of 1 mM) in a 20 μl reaction volume. 10 μl of purified APC/C slurry (see section on Purification of APC/C and APC/CWDR5 complexes) was mixed with TCEP-treated MBPWDR5 (at a final concentration of 2 μM) and BMB (at a final concentration of 20 μM) and incubated for 30 min at 22°C with shaking. Reactions were stopped by adding 2× urea sample buffer and resolved on SDS-acrylamide gels.
K11/K48 denaturing immunoprecipitations
Denaturing K11/K48-linked ubiquitin IPs were performed from cells arrested in prometaphase. Three 15-cm plates of confluent cells were harvested and lysed in equal pellet volume with urea lysis buffer (20 mM Tris 7.5, 135 mM NaCl, 10% glycerol, 8 M urea, 1% Triton X-100, 5 μM carfilzomib (Selleck, PR-171), 10 mM N-ethylmaleimide (NEM), 1× phosSTOP™ (Roche, 4906837001), and 1× cOmplete™ protease inhibitor cocktail (Roche, 04693159001)), rotated for 1 h at room temperature, sonicated with a microtip sonicator (15 pulses at 50 Amps), diluted two-fold in dilution buffer (20 mM Tris 7.5, 135 mM NaCl, 10% glycerol, 5 μM carfilzomib, 10 mM NEM, 1× phosSTOP™, and 1× cOmplete™ protease inhibitor cocktail), and clarified for 5 min at low speed (2400 × g). Clarified extracts were incubated with 20 μg of anti-K11/K48 bispecific ubiquitin antibody or control normal mouse IgG and 40 μl of protein G-agarose slurry for 3 h at room temperature. Beads were washed 10× with dilution buffer, eluted with 2× urea sample buffer, and resolved on SDS-acrylamide gels.
Mass spectrometry
Mass spectrometry was performed on immunoprecipitates prepared from HEK 293T cells. Briefly, twenty 15-cm plates of HEK 293T cells were PEI-transfected (if indicated), grown to confluence, synchronized (if indicated), harvested, and lysed in lysis buffer (20 mM HEPES, pH 7.4, 5 mM KCl, 150 mM NaCl, 1.5 mM MgCl2, 0.1% Nonidet P-40, and 1× cOmplete™ protease inhibitor cocktail). Lysed extracts were clarified by high speed centrifugation, pre-cleared with protein G-agarose slurry and bound to indicated antibodies pre-coupled to protein G-agarose resin (for IPs of endogenous) or anti-FLAG® M2 affinity resin (for IPs of overexpressed proteins). IPs were then washed and eluted 3× at 30°C with 0.5 mg ml−1 of 3×FLAG® peptide (Sigma, F4799) buffered in 1×PBS plus 0.1% Triton X-100. Elutions were pooled and precipitated overnight at 4°C with 20% trichloroacetic acid. IPs were then pelleted, washed 3× with an ice-cold acetone/0.1 N HCl solution, dried, resolubilized in 8 M urea buffered in 100 mM Tris 8.5, reduced with TCEP (at a final concentration of 5 mM) for 20 min, alkylated with iodoacetamide (at a final concentration of 10 mM) for 15 min, diluted four-fold with 100 mM Tris 8.5, and digested with 0.5 mg ml−1 of trypsin supplemented with CaCl2 (at a final concentration of 1 mM) overnight at 37°C. Trypsin-digested samples were submitted to the Vincent J. Coates Proteomics/Mass Spectrometry Laboratory at UC Berkeley for analysis. Peptides were processed using multidimensional protein identification technology (MudPIT) and identified using a LTQ XL linear ion trap mass spectrometer. To identify high confidence interactors, CompPASS analysis of the query mass spectrometry result was performed against mass spectrometry results from unrelated FLAG immunoprecipitates performed in our laboratory.
For TMT labeling, samples were prepared in the same manner as previously described. Following trypsin digestion, however, samples were desalted using a C18 column (Agilent, A57203), dried overnight, resuspended in 80 μl of 200 mM HEPES, pH 8.0, and quantified using the Pierce™ Quantitative Colorimetric Peptide Assay kit (Pierce, 23275) on a microplate reader. Peptides were then normalized to equal masses in 100 μl volumes with 200 mM HEPES, pH 8. TMT labeling was performed using the TMTsixplex™ Isobaric Mass Tagging Kit (Thermo Fisher, 90066) per manufacturer’s instruction. Labeled peptides were combined in equal volumes, desalted, dried, and identified using a Fusion Lumos mass spectrometer by the Vincent J. Coates Proteomics/Mass Spectrometry Laboratory.
Immunofluorescence microscopy
For immunofluorescence analysis of neural inductions, H1s and H1s undergoing neural conversion were seeded on Matrigel coated 96-well plates in mTeSR™1 or STEMdiff™ Neural Induction Medium plus 10 μM Y-27632 for 24 h, washed with 1×PBS plus 1 mM MgCl2 and 1 mM CaCl2, fixed with 4% paraformaldehyde buffered in 1×PBS for 15 min, permeabilized in 1×PBS plus 0.1% Triton X-100 for 10 min, blocked in 10% FBS plus 0.1% Triton X-100 for 30 min, and stained with indicated antibodies diluted in 10% FBS plus 0.1% Triton X-100. Images were taken on an Opera Phenix High-Content Screening System (PerkinElmer) using a 40× air objective and processed using Harmony High Content Imaging and Analysis Software (PerkinElmer).
Live-cell imaging
H2B-mcherry expressing H1s were transfected with indicated siRNAs and seeded on Matrigel-coated 8-chamber microscopy slides (Lab-Tel®II, 155409). 24–48 h post transfection, cells were imaged every 3 minutes for 12–14 h using a Zeiss LSM 710 confocal microscope with 20× objective. Mitotic cells were identified manually.
Analysis of cell cycle progression
For DNA content analysis, single cell suspensions were generated with trypsin, fixed for 15 min with 4% paraformaldehyde buffered in 1×PBS, washed with 1×PBS, and incubated with 2 μg ml−1 of Hoescht 33342 buffered in 1×PBS for 30 min at room temperature with gentle rocking. Single cells were filtered through a mesh strainer and analyzed using an LSRFortessa™ flow cytometer (Becton Dickinson). Cytometry data were processed using the FlowCytometryTools Python package and custom-built Python scripts.
Sonication/ChIP-qPCR analysis
Cells were resuspended in 1×PBS and fixed at room temperature with 1% formaldehyde (Fisher, UN1198) for 10 min or with 1.5 mM ethylene glycol bis(succinimidyl succinate) (EGS) for 20 min followed by 1% formaldehyde for an additional 10 min. Crosslinking reactions were quenched with 125 mM glycine buffered in 1×PBS for 10 minutes. Crosslinked cells were washed twice with 1×PBS, harvested, snap frozen and stored at −80°C for later use. Harvested pellets were resuspended in sonication buffer (50 mM Tris 8.0, 10 mM EDTA, 1% SDS, and 1× cOmplete™ protease inhibitor cocktail), incubated on ice for 15 min, and pelleted at 2000 × g. Pellets were washed 4× with sonication buffer and sonicated in 12×24 mm tubes (Covaris, 520056) at 150 W (peak power) using an S220 ultrasonicator (Covaris) with a duty factor of 20 and 200 cycles per burst for 30–35 cycles (30s on/30s off) . Sonicated extracts were clarified by high speed centrifugation, snap frozen and stored at −80°C for later use. ChIP extracts were diluted 10-fild in dilution buffer (20 mM Tris 8.0, 167 mM NaCl, 1 mM EDTA, 1% Triton X-100, and 1× cOmplete™ protease inhibitor cocktail), precleared with protein G/A-agarose resin, and bound overnight to indicated antibodies (Supplementary Table 2) at 4°C. Antibodies were pulled down by addition of BSA-blocked protein G/A-agarose resin. Beads were washed twice with low salt wash buffer (20 mM Tris 8.0, 150 mM NaCl, 2 mM EDTA, 1% Triton X-100, and 0.1% SDS), twice with high salt wash buffer (20 mM Tris 8.0, 500 mM NaCl, 2 mM EDTA, 1% Triton X-100, and 0.1% SDS), once with LiCl buffer (20 mM Tris 8.0, 250 mM LiCl, 1 mM EDTA, 1% deoxycholate, and 1% Nonidet P-40), and twice with 1×TE. Samples were eluted twice at 30°C with 1% SDS buffered in 1×TE. Eluates were pooled, treated with RNAse A, and reverse crosslinked overnight at 65°C. Samples were then treated with proteinase K, phenol:chloroform extracted, isopropanol precipitated, and eluted in 10 mM Tris 8. Resuspended samples were quantified using the KAPA SYBR® FAST Universal kit (Kapa Biosystems, KK406) on a QuantStudio 6 Flex Real-Time PCR System (Applied Biosystems). ChIP-qPCR primers used in this study can be found in Supplementary Table 3.
Real-time qPCR (qRT–PCR) analysis
For RT–qPCR analysis, total RNA was purified from cells using the NucleoSpin® RNA kit (Macherey-Nagel, no. 740955) or with acid phenol and reverse transcribed using the Maxima First Strand cDNA Synthesis kit (Thermo Fisher, K1671). Expression levels were quantified using the Luna® Universal qPCR Master Mix (NEB, M3003) on a QuantStudio 6 Flex Real-Time PCR System (Applied Biosystems). RT-qPCR primers used in this study can be found in Supplementary Table 3.
Sonication/ChIPseq analysis
For sonication/ChIPseq analysis, samples were prepared in the same manner as described for sonication/ChIP-qPCR analysis (see previous section). Libraries were constructed by the Functional Genomics Laboratory at UC Berkeley, multiplexed, and sequenced by the Vincent J. Coates Genomics Sequencing Laboratory at UC Berkeley on a HiSeq2500 or a HiSeq4000 (Illumina). Alignments for the paired-end or single-read sequencing runs were performed against the hg19 reference genome using Bowtie2. ChIP peaks were called with MACS14. Downstream analyses were performed using Bedtools and Deeptools.
MNase/ChIPseq sample preparation
For MNase/ChIPseq analysis, hESCs were harvested by accutase treatment, washed once with ice-cold 1×PBS, and resuspended in 1 ml of 1×PBS. Single cell suspensions were crosslinked with 1% formaldehyde for 10 min at room temperature, quenched with glycine (at a final concentration of 125 mM) for 2 min, washed with 1×PBS, snap frozen in liquid nitrogen and stored at −80°C for later use. Frozen pellets were resuspended in an equal pellet volume of lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris 8.0, 1× cOmplete™ protease inhibitor cocktail, and 1× phosSTOP™), incubated on ice for 10 min, diluted four-fold with dilution buffer (1% Triton X-100, 150 mM NaCl, 20 mM Tris 8.0, 2.5 mM CaCl2, 1× cOmplete™ protease inhibitor cocktail, and 1× phosSTOP™), digested with 150 units of micrococcal nuclease (Worthington, LS004798) per 200 μl of pellet volume for 5 min at 37°C, quenched with 6 mM EDTA and 6 mM EGTA, spun at 20,000×g to remove debris, aliquoted, snap frozen in liquid nitrogen and stored at −80°C for later use. MNase-digested chromatin was precleared with protein-G dynabeads (Thermo, 10003D) and bound to indicated antibodies overnight at 4°C. Antibodies were immunoprecipitated by addition of BSA-blocked protein-G dynabeads. Beads were washed twice with low salt wash buffer (20 mM Tris 8.0, 150 mM NaCl, 2 mM EDTA, 1% Triton X-100, and 0.1% SDS), twice with high salt wash buffer (20 mM Tris 8.0, 500 mM NaCl, 2 mM EDTA, 1% Triton X-100, and 0.1% SDS), once with LiCl buffer (20 mM Tris 8.0, 250 mM LiCl, 1 mM EDTA, 1% deoxycholate, and 1% Nonidet P-40), and twice with 1×TE. Samples were eluted twice at 30°C with 1% SDS buffered in 1×TE. Eluates were pooled, treated with RNAse A, and reverse crosslinked overnight at 65°C. Samples were then treated with proteinase K, phenol:chloroform extracted, isopropanol precipitated, and eluted in 10 mM Tris 8.
MNase/ChIPseq library construction
Purified DNA (see previous section) was quantified by Fragment Analyzer (Agilent). 25 ng of purified DNA was resuspended up to 50 μl in water. 10 μl of T4 DNA ligase buffer (NEB, B0202), 4 μl of 10 mM dNTPs, 5 μl of T4 DNA polymerase (NEB, M0203), 1 μl of Klenow DNA polymerase (NEB, M0210), 5 μl of T4 DNA polynucleotide kinase (NEB, M0201), and 25 μl of water was added to the diluted input DNA and incubated at 25°C for 30 min. Samples were purified with Ampure XP beads (Beckman, A36881) and resuspended in 32 μl of water. 5 μl of buffer 2 (NEB, B7002), 1 μl of 10 mM dATP, 3 μl of Klenow fragment (NEB, M0212), and 9 μl of water was added to the end-repaired DNA and incubated at 37°C for 30 min. Samples were purified with Ampure XP beads (Beckman, A36881) and resuspended in 23 μl of water. 5 μl of Truseq Y adaptors for paired-end sequencing (custom-made), 5 μl of 10× ligase buffer (NEB, B0202), 1.5 μl of T4 DNA ligase (NEB, M0202), and 15.5 μl of water was added to the 3’-adenylated DNA and incubated at room temperature for 1 h. Samples were purified with Ampure XP beads (Beckman, A36881) and resuspended in 30 μl of water. 3 μl of adaptor ligated DNA was used for PCR amplification (KAPA HiFi master mix, KK201).
MNase/ChIPseq sequencing and analysis
MNase/ChIPseq samples (see previous section) were multiplexed and sequenced by the Vincent J. Coates Genomics Sequencing Laboratory at UC Berkeley on a HiSeq4000 (Illumina). Alignments for the single-read sequencing runs were performed against the hg19 reference genome using Bowtie2. ChIP peaks were called with MACS14. Downstream analyses were performed using Bedtools and Deeptools.
RNAseq sample preparation and analysis
Total RNA was purified from cells with TRIzol (Thermo, 15596026) and digested with TURBO DNase (Thermo, AM2238). Total RNA was poly(A)-selected and sequencing libraries were constructed using the KAPA mRNA HyperPrep kit (KK8580) by the Functional Genomics Laboratory at UC Berkeley. Libraries were sequenced by the Vincent J. Coates Genomics Sequencing Laboratory at UC Berkeley on a HiSeq4000 (Illumina). Gene expression analysis was performed using Kallisto against hg19 as the reference genome.
Bioinformatics
Identified ChIP peaks were subjected to bioinformatic analyses. GO enrichment analyses were performed using DAVID 6.8 (https://david.ncifcrf.gov). Comparison with SAGE data was performed using the CGAP-SAGE feature of DAVID, a web-based application (https://david.ncifcrf.gov).
Purification of phosphomimetic APC/CCDC20 with WDR5 for Negative Stain EM
Recombinant APC/CCDC20 harboring glutamate mutations mimicking phosphorylation 37 was purified as described previously 38. Briefly, APC/C and CDC20 were expressed independently in High Five insect cells (Thermo Fisher Scientific) and co-lysed by mixing and sonication. Cleared lysate was treated to tandem Strep- and GST-affinity chromatography selections for APC2 and APC16, respectively. GST elution fractions containing APC/CCDC20 were combined with TEV-protease, HRV14 3C-protease, and purified MBP-FLAG-WDR5-His harboring a TEV proteolytic site N-terminal of the FLAG tag. This mixture was further purified through FLAG affinity chromatography and eluted with antigenic peptides.
Negative Stain Electron Microscopy
For negative stain-EM studies, 125 μg of purified APC/CCDC20-WDR5 eluate from FLAG IPs was loaded onto a 10%–40% glycerol gradient containing 50 mM HEPES pH 8.0, 200 mM NaCl, and 2 mM MgCl2. For particle fixation by GraFix (Kastner et al., 2008), the gradient also contained 0.025% and 0.1% glutaraldehyde in the lighter and denser glycerol solution, respectively, creating an additional glutaraldehyde gradient from top to bottom (0.025–0.1%). Centrifugation was performed at 34,000 rpm in a TH-660 rotor (Thermo-Fisher Scientific) for 15 h at 0°C and the solution was subsequently fractionated. APC/C particles were allowed to adsorb on a thin film of carbon, transferred onto a plasma-cleaned lacey grid (LC200-CU, Electron Microscopy Services), and then stained for 2 min with a 4% (w/v) uranyl formate solution. Micrographs were collected on a FEI Titan Halo at 300 KV with a Falcon 2 direct detector (FEI) (MPI of Biochemistry, Martinsried, Germany). The nominal magnification was 45,000 x, resulting in an image pixel size of 2.37 Å per pixel on the object scale and data were collected in a defocus range of 1.5–3.5 μM. Particles were autopicked using Relion (Scheres, 2012). The contrast transfer function parameters were determined using CTFFIND4 (Rohou et al., 2015). Using Relion, particles were extracted from micrographs and subjected to 2D classification. Inconsistent class averages were removed prior to 3D classification in Relion.
Structural modeling was performed using UCSF Chimera (1.13.1) 39. To identify EM density corresponding to WDR5, the EM reconstruction of APC/CCDC20-WDR5 obtained from 3D classification in Relion was superimposed with a prior map from an APC/CCDC20-substrate complex (EMDB-3385, ref. 40) low-pass filtered to a comparable resolution. Although the resolution precludes definitive structural modeling, it allowed approximate, global placement of the crystal structures of WDR5 41, along with the APC2 WHB (winged-helix box) and APC11 RING domains 38,42, which are known to be mobile and to adopt distinct orientations when bound to different APC/C partner proteins.
Data Availability Statement
All original data is available on request. CHIPseq and RNAseq data have been deposited at GEO (GSE122298).
Code Availability Statement
Custom python scripts are available on request.
Extended Data
Supplementary Material
Acknowledgements
We thank Nick Ingolia, Robert Tjian, Brenda Schulman, Julia Schaletzky, and all members of Michael Rape’s lab for advice, helpful discussions, and comments on the manuscript. We are grateful to Marissa Matsumoto and Vishva Dixit for generously supplying us with linkage-specific ubiquitin antibodies. EO was funded by the Jane Coffin Childs Memorial Fund for Medical Research and the Siebel Stem Cell Institute. KGM was funded by the NIH F32 postdoctoral fellowship (F32GM120956). AM was funded by the American Italian Cancer foundation and the California Institute for Regenerative Medicine. MR is an Investigator of the Howard Hughes Medical Institute. This work was also funded by an NIH grant (RO1GM083064) awarded to MR.
Footnotes
Competing interests
MR is a co-founder and consultant to Nurix Therapeutics, a biotech company working in the ubiquitin space.
References
- 1.Young RA Control of the embryonic stem cell state. Cell 144, 940–954, doi:S0092-8674(11)00071-7 [pii] 10.1016/j.cell.2011.01.032 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Michelotti EF, Sanford S & Levens D Marking of active genes on mitotic chromosomes. Nature 388, 895–899, doi: 10.1038/42282 (1997). [DOI] [PubMed] [Google Scholar]
- 3.Teves SS et al. A stable mode of bookmarking by TBP recruits RNA polymerase II to mitotic chromosomes. Elife 7, doi: 10.7554/eLife.35621 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Palozola KC et al. Mitotic transcription and waves of gene reactivation during mitotic exit. Science 358, 119–122, doi: 10.1126/science.aal4671 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Hsiung CC et al. A hyperactive transcriptional state marks genome reactivation at the mitosis-G1 transition. Genes Dev 30, 1423–1439, doi: 10.1101/gad.280859.116 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Thomas LR et al. Interaction with WDR5 promotes target gene recognition and tumorigenesis by MYC. Mol Cell 58, 440–452, doi: 10.1016/j.molcel.2015.02.028 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Wysocka J et al. WDR5 associates with histone H3 methylated at K4 and is essential for H3 K4 methylation and vertebrate development. Cell 121, 859–872, doi: 10.1016/j.cell.2005.03.036 (2005). [DOI] [PubMed] [Google Scholar]
- 8.Keyes BE & Fuchs E Stem cells: Aging and transcriptional fingerprints. J Cell Biol 217, 79–92, doi: 10.1083/jcb.201708099 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Prescott DM & Bender MA Synthesis of RNA and protein during mitosis in mammalian tissue culture cells. Exp Cell Res 26, 260–268 (1962). [DOI] [PubMed] [Google Scholar]
- 10.Martinez-Balbas MA, Dey A, Rabindran SK, Ozato K & Wu C Displacement of sequence-specific transcription factors from mitotic chromatin. Cell 83, 29–38 (1995). [DOI] [PubMed] [Google Scholar]
- 11.Caravaca JM et al. Bookmarking by specific and nonspecific binding of FoxA1 pioneer factor to mitotic chromosomes. Genes Dev 27, 251–260, doi: 10.1101/gad.206458.112 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Festuccia N et al. Mitotic binding of Esrrb marks key regulatory regions of the pluripotency network. Nat Cell Biol 18, 1139–1148, doi: 10.1038/ncb3418 (2016). [DOI] [PubMed] [Google Scholar]
- 13.Kadauke S et al. Tissue-specific mitotic bookmarking by hematopoietic transcription factor GATA1. Cell 150, 725–737, doi: 10.1016/j.cell.2012.06.038 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Rape M Ubiquitylation at the crossroads of development and disease. Nat Rev Mol Cell Biol 19, 59–70, doi: 10.1038/nrm.2017.83 (2018). [DOI] [PubMed] [Google Scholar]
- 15.Buckley SM et al. Regulation of pluripotency and cellular reprogramming by the ubiquitin-proteasome system. Cell stem cell 11, 783–798, doi: 10.1016/j.stem.2012.09.011 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Gao J et al. The CUL4-DDB1 ubiquitin ligase complex controls adult and embryonic stem cell differentiation and homeostasis. Elife 4, doi: 10.7554/eLife.07539 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Hu G et al. A genome-wide RNAi screen identifies a new transcriptional module required for self-renewal. Genes Dev 23, 837–848, doi:23/7/837 [pii] 10.1101/gad.1769609 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Yau RG et al. Assembly and Function of Heterotypic Ubiquitin Chains in Cell-Cycle and Protein Quality Control. Cell 171, 918–933 e920, doi: 10.1016/j.cell.2017.09.040 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Stegmeier F et al. Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activities. Nature 446, 876–881, doi:nature05694 [pii] 10.1038/nature05694 (2007). [DOI] [PubMed] [Google Scholar]
- 20.Ang YS et al. Wdr5 mediates self-renewal and reprogramming via the embryonic stem cell core transcriptional network. Cell 145, 183–197, doi: 10.1016/j.cell.2011.03.003 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Pijnappel WW et al. A central role for TFIID in the pluripotent transcription circuitry. Nature 495, 516–519, doi: 10.1038/nature11970 (2013). [DOI] [PubMed] [Google Scholar]
- 22.Karatas H et al. High-affinity, small-molecule peptidomimetic inhibitors of MLL1/WDR5 protein-protein interaction. J Am Chem Soc 135, 669–682, doi: 10.1021/ja306028q (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Mark KG, Loveless TB & Toczyski DP Isolation of ubiquitinated substrates by tandem affinity purification of E3 ligase-polyubiquitin-binding domain fusions (ligase traps). Nature protocols 11, 291–301, doi: 10.1038/nprot.2016.008 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Fuchs G et al. RNF20 and USP44 regulate stem cell differentiation by modulating H2B monoubiquitylation. Molecular cell 46, 662–673, doi: 10.1016/j.molcel.2012.05.023 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Chang L, Zhang Z, Yang J, McLaughlin SH & Barford D Molecular architecture and mechanism of the anaphase-promoting complex. Nature, doi: 10.1038/nature13543 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Meyer HJ & Rape M Enhanced protein degradation by branched ubiquitin chains. Cell 157, 910–921, doi: 10.1016/j.cell.2014.03.037 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Matsumoto ML et al. K11-linked polyubiquitination in cell cycle control revealed by a K11 linkage-specific antibody. Mol Cell 39, 477–484, doi:S1097-2765(10)00523-X [pii] 10.1016/j.molcel.2010.07.001 (2010). [DOI] [PubMed] [Google Scholar]
- 28.Aho ER et al. Displacement of WDR5 from Chromatin by a WIN Site Inhibitor with Picomolar Affinity. Cell Rep 26, 2916–2928 e2913, doi: 10.1016/j.celrep.2019.02.047 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.King RW et al. A 20S complex containing CDC27 and CDC16 catalyzes the mitosis-specific conjugation of ubiquitin to cyclin B. Cell 81, 279–288 (1995). [DOI] [PubMed] [Google Scholar]
- 30.Blobel GA et al. A reconfigured pattern of MLL occupancy within mitotic chromatin promotes rapid transcriptional reactivation following mitotic exit. Mol Cell 36, 970–983, doi: 10.1016/j.molcel.2009.12.001 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Pilaz LJ et al. Prolonged Mitosis of Neural Progenitors Alters Cell Fate in the Developing Brain. Neuron 89, 83–99, doi: 10.1016/j.neuron.2015.12.007 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Halley-Stott RP, Jullien J, Pasque V & Gurdon J Mitosis gives a brief window of opportunity for a change in gene transcription. PLoS Biol 12, e1001914, doi: 10.1371/journal.pbio.1001914 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Egli D, Birkhoff G & Eggan K Mediators of reprogramming: transcription factors and transitions through mitosis. Nat Rev Mol Cell Biol 9, 505–516, doi: 10.1038/nrm2439 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Tsankov AM et al. Transcription factor binding dynamics during human ES cell differentiation. Nature 518, 344–349, doi: 10.1038/nature14233 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Chambers SM et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 27, 275–280, doi: 10.1038/nbt.1529 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Kampmann M, Bassik MC & Weissman JS Functional genomics platform for pooled screening and generation of mammalian genetic interaction maps. Nature protocols 9, 1825–1847, doi: 10.1038/nprot.2014.103 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Qiao R et al. Mechanism of APC/CCDC20 activation by mitotic phosphorylation. Proc Natl Acad Sci U S A 113, E2570–2578, doi: 10.1073/pnas.1604929113 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Brown NG et al. RING E3 mechanism for ubiquitin ligation to a disordered substrate visualized for human anaphase-promoting complex. Proc Natl Acad Sci U S A, doi: 10.1073/pnas.1504161112 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Pettersen EF et al. UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem 25, 1605–1612, doi: 10.1002/jcc.20084 (2004). [DOI] [PubMed] [Google Scholar]
- 40.Zhang S et al. Molecular mechanism of APC/C activation by mitotic phosphorylation. Nature 533, 260–264, doi: 10.1038/nature17973 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Zhang P, Lee H, Brunzelle JS & Couture JF The plasticity of WDR5 peptide-binding cleft enables the binding of the SET1 family of histone methyltransferases. Nucleic Acids Res 40, 4237–4246, doi: 10.1093/nar/gkr1235 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Brown NG et al. Mechanism of polyubiquitination by human anaphase-promoting complex: RING repurposing for ubiquitin chain assembly. Mol Cell 56, 246–260, doi: 10.1016/j.molcel.2014.09.009 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All original data is available on request. CHIPseq and RNAseq data have been deposited at GEO (GSE122298).